Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: The MEDIC study

Pharmacotherapy

Volumn 28, Issue 7, 2008, Pages 834-842

  Munger, Mark A ^a,b   Gardner, Stephanie F ^c   Ateshkadi, Arasb ^a   Rabetoy, Gary M ^b   Barri, Yoursi M ^d   Stoddard, Gregory J ^b   Cheung, Alfred K ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cardiorenal changes; Diclofenac; Hypertension; Misoprostol; Nonsteroidal antiinflammatory drug; NSAID

Indexed keywords

ANTIHYPERTENSIVE AGENT; DICLOFENAC; MISOPROSTOL; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART HEMODYNAMICS; HEART RATE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; PLASMA CLEARANCE; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; CROSS-OVER STUDIES; DICLOFENAC; DOUBLE-BLIND METHOD; HUMANS; HYPERTENSION; KIDNEY; MIDDLE AGED; MISOPROSTOL; PROSPECTIVE STUDIES; SODIUM CHLORIDE;

EID: 45749110604     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.7.834     Document Type: Article

References (33)

1. O'Brien WM, Bagby GF. Rare adverse reactions to nonsteroidal antiinflammatory drugs: part 1. J Rheumatol 1985;12:13-20.
2. Johnson AG, Simons LA, Simons J, Friedlander Y, McCallum J. Non-steroidal antiinflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol 1993;35:455-9.
3. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994;121:289-300.
4. Whelton A, Hamilton CW. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol 1991;31:588-98.
5. Johnson AG. NSAIDs and blood pressure: clinical importance for older patients. Drugs Aging 1998;12:17-27.
6. Kannel WB, Wolf PA, Verter J, McNamara PM. Epidemiology of essential hypertension: the Framingham experience. 1970;214:301-10.
7. Murray MD, Brater DC. Adverse effects of nonsteroidal anti-inflammatory drugs on renal function: misoprostol and ranitidine in the prevention of NSAID-induced ulcers - a prospective, double-blind, multicenter study. Am J Gastroenterol 1996;91:223-7.
8. G.D. Searle and Co. Cytotec (misoprostol) product monograph. Skokie, IL; 1995.
9. Brecht T. Effects of misoprostol on human circulation. Prostaglandins 1987;33(suppl):51-60.
10. Hayashida M, Hanaoka K, Shimada Y, Namiki A, Amaha K. The effect of low-dose prostaglandin E1 on circulation, respiration and body temperature during surgical anesthesia. Masui 1987;1997:46:363-72.
11. Bakris GL. Renal effects of oral prostaglandin supplementation after ibuprofen in diabetic subjects: a double-blind, placebo-controlled, multicenter trial. J Am Soc Nephrol 1995;5:1684-8.
12. Chobanian AV, Bakris GL, Black HR, et al, for the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; the National Heart, Lung, and Blood Institute; and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52.
13. Zambraski EJ. The effects of nonsteroidal anti-inflammatory drugs on renal function: experimental studies in animals. Semin Nephrol 1995;15:205-13.
14. Ferri C, Bellini C, Piccoli A, et al. Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension. Hypertension 1993;21:875-81.
15. Sheps SG, Elveback LR, Close EL, Kleven MK, Bissen C. Evaluation of the Del Mar Avionics automatic ambulatory blood pressure-recording device. Mayo Clinic Proc 1981;56:740-3.
16. Bell RR, Bombardt PA, DuCharme DW, et al. A non-radioactive iothalamate and p-aminohippuric acid high-performance liquid chromatographic method for simultaneously measuring glomerular filtration rate and renal blood flow in the rat. Biomed Chromatogr 1994;8:224-9.
17. StatXact 4 for Windows. Statistical software for exact nonparametric inference user manual. Cambridge, MA: Cytel Softward Corporation, 1998:171-5.
18. Mookerjee BK, Patak RV, Bentzel CJ, Lee JB. Indomethacin antagonism of the effects of furosemide in normal and hypertensive man [abstract]. Kidney Int 1975;8:441.
19. Spühler O, Zollinger HO. Die chronisch-interstitielle nephritis. Z Klin Med 1953;151:1-50.
20. Hornych A, Forette F, Bariety J, Krief C, Aumont J, Paris M. The influence of age on renal prostaglandin synthesis in man. Prostaglandins Leukot Essent Fatty Acids 1991;43:191-5.
21. Palmer BF, Henrich WL. Clinical acute renal failure with nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995;15:214-27.
22. Tobian L, Ganguli M, Johnson MA, Iwai J. Influence of renal prostaglandins and dietary linolaete on hypertension in Dahl S rats. Hypertension 1982;4(suppl II):149-53.
23. Quiron R, Rioux F, Regoli D. The effect of an acute or chronic treatment with indomethacin on the blood pressure of DOCA/salt and spontaneously hypertensive rats. Clin Exp Hypertens 1978;1:267-77.
24. Susie D, Mandal AK, Radujkovic G, Vulovic D, Kentura D. Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats. J Lab Clin Med 1988;111:63-76.
25. Boers M, Dijkmans BAC, Breedveld FC, et al. No effect of misoprostol on renal function of rheumatoid patients treated with diclofenac. Brit J Rhematol 1991;30:56-9.
26. Fullerton T, Sica DA, Blum RA. Evaluation of the renal protective effect of misoprostol in elderly, osteoarthritic patients at risk for nonsteroidal anti-inflammatory drug-induced renal dysfunction. J Clin Pharmacol 1993;33:1225-32.
27. Weir MR, Klassen DK, Hall PS, et al. Minimization of indomethacin-induced reduction in renal function by misoprostol. J Clin Pharmacol 1991;31:729-35.
28. 3 receptor-mediated inhibition of the neurogenic vasopressor response in pithed rats. Eur J Pharmacol 1994;259:315-19.
29. 1 infusion in man. Nephron 1992;60:42-8.
30. Schlondorff D. Renal prostaglandin synthesis: sites of production and specific actions of prostaglandins. Am J Med 1986;81(suppl 2B):1-11.
31. Dunn MJ. Nonsteroidal anti-inflammatory drugs and renal function. Annu Rev Med 1984;35:411-28.
32. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
33. Deedwania PC, Nelson JR. Pathophsiology of silent myocardial ischemia during daily life: hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 1990;82:1296-304.